Balance Sheet
Cash Flow Statement
AmortizationAmortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GNMSF) Change in Acquisitions & Divestments (2024 - 2025)

Historic Change in Acquisitions & Divestments for Genmab A (GNMSF) over the last 2 years, with Q4 2025 value amounting to $1.7 billion.

  • Genmab A's Change in Acquisitions & Divestments rose 57142.86% to $1.7 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.6 billion, marking a year-over-year increase of 6026.89%. This contributed to the annual value of $2.6 billion for FY2025, which is 6026.89% up from last year.
  • Latest data reveals that Genmab A reported Change in Acquisitions & Divestments of $1.7 billion as of Q4 2025, which was up 57142.86% from $335.0 million recorded in Q3 2025.
  • In the past 5 years, Genmab A's Change in Acquisitions & Divestments ranged from a high of $1.7 billion in Q4 2025 and a low of $252.0 million during Q4 2024